Project
Illumina Body Map 2, young vs old
Navigation
Downloads
Results for E2F6
Z-value: 0.33
Motif logo
Transcription factors associated with E2F6
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
E2F6
|
ENSG00000169016.12 | E2F transcription factor 6 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| E2F6 | hg19_v2_chr2_-_11605966_11606005 | 0.27 | 1.3e-01 | Click! |
Activity profile of E2F6 motif
Sorted Z-values of E2F6 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr8_+_95653427 | 4.54 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr8_+_95653373 | 4.00 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr20_+_44098346 | 3.77 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
| chr20_+_44098385 | 3.68 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
| chr12_+_58005204 | 3.52 |
ENST00000286494.4
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
| chr8_+_95653302 | 3.33 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr11_+_46402583 | 3.15 |
ENST00000359803.3
|
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr21_+_47401650 | 2.74 |
ENST00000361866.3
|
COL6A1
|
collagen, type VI, alpha 1 |
| chrX_-_133119476 | 2.70 |
ENST00000543339.1
|
GPC3
|
glypican 3 |
| chrX_-_128788914 | 2.62 |
ENST00000429967.1
ENST00000307484.6 |
APLN
|
apelin |
| chr7_+_24323782 | 2.55 |
ENST00000242152.2
ENST00000407573.1 |
NPY
|
neuropeptide Y |
| chr5_-_149682447 | 2.46 |
ENST00000328668.7
|
ARSI
|
arylsulfatase family, member I |
| chr11_+_46402744 | 2.41 |
ENST00000533952.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr14_-_94254821 | 2.40 |
ENST00000393140.1
|
PRIMA1
|
proline rich membrane anchor 1 |
| chr7_+_94023873 | 2.39 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
| chr19_-_291365 | 2.37 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
| chr20_-_18038521 | 2.34 |
ENST00000278780.6
|
OVOL2
|
ovo-like zinc finger 2 |
| chr1_+_210406121 | 2.27 |
ENST00000367012.3
|
SERTAD4
|
SERTA domain containing 4 |
| chr14_+_104604916 | 2.24 |
ENST00000423312.2
|
KIF26A
|
kinesin family member 26A |
| chr1_+_114522049 | 2.21 |
ENST00000369551.1
ENST00000320334.4 |
OLFML3
|
olfactomedin-like 3 |
| chr7_+_20370746 | 2.20 |
ENST00000222573.4
|
ITGB8
|
integrin, beta 8 |
| chr16_-_65155979 | 2.20 |
ENST00000562325.1
ENST00000268603.4 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
| chr1_+_201979645 | 2.19 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chr1_+_201979743 | 2.16 |
ENST00000446188.1
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chr15_-_41166414 | 2.11 |
ENST00000220507.4
|
RHOV
|
ras homolog family member V |
| chr17_-_74137374 | 2.10 |
ENST00000322957.6
|
FOXJ1
|
forkhead box J1 |
| chr15_-_83316254 | 2.06 |
ENST00000567678.1
ENST00000450751.2 |
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
| chr2_+_79740118 | 2.04 |
ENST00000496558.1
ENST00000451966.1 |
CTNNA2
|
catenin (cadherin-associated protein), alpha 2 |
| chr14_+_102027688 | 2.04 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
| chr16_+_67465016 | 2.03 |
ENST00000326152.5
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2 |
| chr20_-_4229721 | 2.02 |
ENST00000379453.4
|
ADRA1D
|
adrenoceptor alpha 1D |
| chrX_-_139587225 | 2.00 |
ENST00000370536.2
|
SOX3
|
SRY (sex determining region Y)-box 3 |
| chr2_+_105471969 | 1.99 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
| chr15_+_42867857 | 1.95 |
ENST00000290607.7
|
STARD9
|
StAR-related lipid transfer (START) domain containing 9 |
| chr7_-_130080681 | 1.95 |
ENST00000469826.1
|
CEP41
|
centrosomal protein 41kDa |
| chr5_+_3596168 | 1.95 |
ENST00000302006.3
|
IRX1
|
iroquois homeobox 1 |
| chr19_-_42947121 | 1.94 |
ENST00000601181.1
|
CXCL17
|
chemokine (C-X-C motif) ligand 17 |
| chr10_+_102505468 | 1.93 |
ENST00000361791.3
ENST00000355243.3 ENST00000428433.1 ENST00000370296.2 |
PAX2
|
paired box 2 |
| chr2_-_166651152 | 1.92 |
ENST00000431484.1
ENST00000412248.1 |
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
| chr11_-_9113137 | 1.90 |
ENST00000520467.1
ENST00000309263.3 ENST00000457346.2 |
SCUBE2
|
signal peptide, CUB domain, EGF-like 2 |
| chrX_+_146993648 | 1.90 |
ENST00000370470.1
|
FMR1
|
fragile X mental retardation 1 |
| chr2_+_176957619 | 1.90 |
ENST00000392539.3
|
HOXD13
|
homeobox D13 |
| chr17_+_59529743 | 1.89 |
ENST00000589003.1
ENST00000393853.4 |
TBX4
|
T-box 4 |
| chr19_+_34287174 | 1.88 |
ENST00000587559.1
ENST00000588637.1 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
| chr11_+_12399071 | 1.86 |
ENST00000539723.1
ENST00000550549.1 |
PARVA
|
parvin, alpha |
| chr12_+_54519842 | 1.85 |
ENST00000508564.1
|
RP11-834C11.4
|
RP11-834C11.4 |
| chr12_-_48398104 | 1.84 |
ENST00000337299.6
ENST00000380518.3 |
COL2A1
|
collagen, type II, alpha 1 |
| chrX_-_117250740 | 1.83 |
ENST00000371882.1
ENST00000540167.1 ENST00000545703.1 |
KLHL13
|
kelch-like family member 13 |
| chr2_-_20424844 | 1.79 |
ENST00000403076.1
ENST00000254351.4 |
SDC1
|
syndecan 1 |
| chr5_-_159739532 | 1.79 |
ENST00000520748.1
ENST00000393977.3 ENST00000257536.7 |
CCNJL
|
cyclin J-like |
| chrX_-_110039038 | 1.77 |
ENST00000372042.1
ENST00000482160.1 ENST00000444321.2 ENST00000218054.4 |
CHRDL1
|
chordin-like 1 |
| chr19_+_55795493 | 1.77 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
| chr2_-_135476552 | 1.76 |
ENST00000281924.6
|
TMEM163
|
transmembrane protein 163 |
| chr11_-_32457176 | 1.76 |
ENST00000332351.3
|
WT1
|
Wilms tumor 1 |
| chr6_-_10412600 | 1.74 |
ENST00000379608.3
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| chr12_+_52445191 | 1.73 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
| chrX_+_146993534 | 1.73 |
ENST00000334557.6
ENST00000439526.2 ENST00000370475.4 |
FMR1
|
fragile X mental retardation 1 |
| chr2_-_42721110 | 1.72 |
ENST00000394973.4
ENST00000306078.1 |
KCNG3
|
potassium voltage-gated channel, subfamily G, member 3 |
| chr6_+_21666633 | 1.70 |
ENST00000606851.1
|
CASC15
|
cancer susceptibility candidate 15 (non-protein coding) |
| chrX_-_133119670 | 1.70 |
ENST00000394299.2
|
GPC3
|
glypican 3 |
| chr4_-_119274121 | 1.70 |
ENST00000296498.3
|
PRSS12
|
protease, serine, 12 (neurotrypsin, motopsin) |
| chr9_-_127269661 | 1.69 |
ENST00000373588.4
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1 |
| chr1_+_43613612 | 1.69 |
ENST00000335282.4
|
FAM183A
|
family with sequence similarity 183, member A |
| chr9_+_137533615 | 1.69 |
ENST00000371817.3
|
COL5A1
|
collagen, type V, alpha 1 |
| chr16_-_65155833 | 1.67 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
| chr11_-_119293903 | 1.67 |
ENST00000580275.1
|
THY1
|
Thy-1 cell surface antigen |
| chr2_-_166650700 | 1.67 |
ENST00000422973.1
|
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
| chr11_+_394196 | 1.66 |
ENST00000331563.2
ENST00000531857.1 |
PKP3
|
plakophilin 3 |
| chr19_+_797443 | 1.65 |
ENST00000394601.4
ENST00000589575.1 |
PTBP1
|
polypyrimidine tract binding protein 1 |
| chrX_-_110038990 | 1.63 |
ENST00000372045.1
ENST00000394797.4 |
CHRDL1
|
chordin-like 1 |
| chr12_+_49212514 | 1.62 |
ENST00000301050.2
ENST00000548279.1 ENST00000547230.1 |
CACNB3
|
calcium channel, voltage-dependent, beta 3 subunit |
| chr14_-_30396948 | 1.62 |
ENST00000331968.5
|
PRKD1
|
protein kinase D1 |
| chr17_-_42277203 | 1.62 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
| chr1_+_3569129 | 1.60 |
ENST00000354437.4
ENST00000357733.3 ENST00000346387.4 |
TP73
|
tumor protein p73 |
| chrX_-_133119895 | 1.60 |
ENST00000370818.3
|
GPC3
|
glypican 3 |
| chr20_+_20348740 | 1.60 |
ENST00000310227.1
|
INSM1
|
insulinoma-associated 1 |
| chr15_+_41221536 | 1.59 |
ENST00000249749.5
|
DLL4
|
delta-like 4 (Drosophila) |
| chr3_+_77088989 | 1.59 |
ENST00000461745.1
|
ROBO2
|
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
| chr17_+_47653178 | 1.58 |
ENST00000328741.5
|
NXPH3
|
neurexophilin 3 |
| chr7_-_82792215 | 1.58 |
ENST00000333891.9
ENST00000423517.2 |
PCLO
|
piccolo presynaptic cytomatrix protein |
| chr14_-_103989033 | 1.57 |
ENST00000553878.1
ENST00000557530.1 |
CKB
|
creatine kinase, brain |
| chr19_+_38755237 | 1.55 |
ENST00000587516.1
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
| chrX_-_110039286 | 1.55 |
ENST00000434224.1
|
CHRDL1
|
chordin-like 1 |
| chr17_-_27038063 | 1.54 |
ENST00000439862.3
|
PROCA1
|
protein interacting with cyclin A1 |
| chr10_-_104178857 | 1.54 |
ENST00000020673.5
|
PSD
|
pleckstrin and Sec7 domain containing |
| chr19_+_797392 | 1.53 |
ENST00000350092.4
ENST00000349038.4 ENST00000586481.1 ENST00000585535.1 |
PTBP1
|
polypyrimidine tract binding protein 1 |
| chr5_-_524445 | 1.52 |
ENST00000514375.1
ENST00000264938.3 |
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 |
| chr20_+_34680620 | 1.52 |
ENST00000430276.1
ENST00000373950.2 ENST00000452261.1 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
| chr17_+_77751931 | 1.52 |
ENST00000310942.4
ENST00000269399.5 |
CBX2
|
chromobox homolog 2 |
| chr15_+_41851211 | 1.51 |
ENST00000263798.3
|
TYRO3
|
TYRO3 protein tyrosine kinase |
| chr13_-_96296944 | 1.50 |
ENST00000361396.2
ENST00000376829.2 |
DZIP1
|
DAZ interacting zinc finger protein 1 |
| chr13_-_19755975 | 1.50 |
ENST00000400113.3
|
TUBA3C
|
tubulin, alpha 3c |
| chr15_+_89346657 | 1.48 |
ENST00000439576.2
|
ACAN
|
aggrecan |
| chr19_-_6110457 | 1.48 |
ENST00000586302.1
|
RFX2
|
regulatory factor X, 2 (influences HLA class II expression) |
| chr11_+_20691099 | 1.48 |
ENST00000298925.5
ENST00000357134.5 ENST00000325319.5 |
NELL1
|
NEL-like 1 (chicken) |
| chr5_-_132113036 | 1.48 |
ENST00000378706.1
|
SEPT8
|
septin 8 |
| chr14_+_85996471 | 1.48 |
ENST00000330753.4
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
| chr1_+_159141397 | 1.47 |
ENST00000368124.4
ENST00000368125.4 ENST00000416746.1 |
CADM3
|
cell adhesion molecule 3 |
| chr19_+_55999916 | 1.46 |
ENST00000587166.1
ENST00000389623.6 |
SSC5D
|
scavenger receptor cysteine rich domain containing (5 domains) |
| chr11_+_46402482 | 1.45 |
ENST00000441869.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr3_-_87039662 | 1.43 |
ENST00000494229.1
|
VGLL3
|
vestigial like 3 (Drosophila) |
| chr6_+_31126291 | 1.42 |
ENST00000376257.3
ENST00000376255.4 |
TCF19
|
transcription factor 19 |
| chr17_+_1959369 | 1.41 |
ENST00000576444.1
ENST00000322941.3 |
HIC1
|
hypermethylated in cancer 1 |
| chrX_-_17878827 | 1.41 |
ENST00000360011.1
|
RAI2
|
retinoic acid induced 2 |
| chr5_+_55033845 | 1.41 |
ENST00000353507.5
ENST00000514278.2 ENST00000505374.1 ENST00000506511.1 |
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 |
| chr11_+_117947782 | 1.41 |
ENST00000522307.1
ENST00000523251.1 ENST00000437212.3 ENST00000522824.1 ENST00000522151.1 |
TMPRSS4
|
transmembrane protease, serine 4 |
| chr15_-_82338460 | 1.41 |
ENST00000558133.1
ENST00000329713.4 |
MEX3B
|
mex-3 RNA binding family member B |
| chr7_+_73442102 | 1.41 |
ENST00000445912.1
ENST00000252034.7 |
ELN
|
elastin |
| chr5_-_168728103 | 1.40 |
ENST00000519560.1
|
SLIT3
|
slit homolog 3 (Drosophila) |
| chrX_-_128657457 | 1.38 |
ENST00000371121.3
ENST00000371123.1 ENST00000371122.4 |
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
| chr17_-_7832753 | 1.38 |
ENST00000303790.2
|
KCNAB3
|
potassium voltage-gated channel, shaker-related subfamily, beta member 3 |
| chr1_-_153581798 | 1.37 |
ENST00000368704.1
ENST00000368705.2 |
S100A16
|
S100 calcium binding protein A16 |
| chr9_-_23821842 | 1.37 |
ENST00000544538.1
|
ELAVL2
|
ELAV like neuron-specific RNA binding protein 2 |
| chr22_-_46373004 | 1.36 |
ENST00000339464.4
|
WNT7B
|
wingless-type MMTV integration site family, member 7B |
| chr6_-_35464817 | 1.36 |
ENST00000338863.7
|
TEAD3
|
TEA domain family member 3 |
| chr5_-_159739483 | 1.36 |
ENST00000519673.1
ENST00000541762.1 |
CCNJL
|
cyclin J-like |
| chr8_+_37654693 | 1.35 |
ENST00000412232.2
|
GPR124
|
G protein-coupled receptor 124 |
| chr17_+_47653471 | 1.35 |
ENST00000513748.1
|
NXPH3
|
neurexophilin 3 |
| chr9_+_102584128 | 1.35 |
ENST00000338488.4
ENST00000395097.2 |
NR4A3
|
nuclear receptor subfamily 4, group A, member 3 |
| chr5_+_1008910 | 1.34 |
ENST00000296849.5
ENST00000274150.4 ENST00000537972.1 |
NKD2
|
naked cuticle homolog 2 (Drosophila) |
| chr11_-_9113093 | 1.34 |
ENST00000450649.2
|
SCUBE2
|
signal peptide, CUB domain, EGF-like 2 |
| chr17_+_30593195 | 1.34 |
ENST00000431505.2
ENST00000269051.4 ENST00000538145.1 |
RHBDL3
|
rhomboid, veinlet-like 3 (Drosophila) |
| chr3_+_119421849 | 1.34 |
ENST00000273390.5
ENST00000463700.1 |
MAATS1
|
MYCBP-associated, testis expressed 1 |
| chr11_+_73019282 | 1.34 |
ENST00000263674.3
|
ARHGEF17
|
Rho guanine nucleotide exchange factor (GEF) 17 |
| chr19_-_14629224 | 1.33 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
| chr12_+_54332535 | 1.32 |
ENST00000243056.3
|
HOXC13
|
homeobox C13 |
| chr15_+_63340647 | 1.32 |
ENST00000404484.4
|
TPM1
|
tropomyosin 1 (alpha) |
| chr1_+_233463507 | 1.31 |
ENST00000366623.3
ENST00000366624.3 |
MLK4
|
Mitogen-activated protein kinase kinase kinase MLK4 |
| chr6_-_10415470 | 1.30 |
ENST00000379604.2
ENST00000379613.3 |
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| chr19_-_38878632 | 1.30 |
ENST00000586599.1
ENST00000334928.6 ENST00000587676.1 |
GGN
|
gametogenetin |
| chr1_-_85358850 | 1.30 |
ENST00000370611.3
|
LPAR3
|
lysophosphatidic acid receptor 3 |
| chr10_-_8095412 | 1.29 |
ENST00000458727.1
ENST00000355358.1 |
RP11-379F12.3
GATA3-AS1
|
RP11-379F12.3 GATA3 antisense RNA 1 |
| chr14_+_85996507 | 1.29 |
ENST00000554746.1
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
| chr17_+_4710391 | 1.29 |
ENST00000263088.6
ENST00000572940.1 |
PLD2
|
phospholipase D2 |
| chr1_-_37499726 | 1.29 |
ENST00000373091.3
ENST00000373093.4 |
GRIK3
|
glutamate receptor, ionotropic, kainate 3 |
| chr15_-_88799661 | 1.29 |
ENST00000360948.2
ENST00000357724.2 ENST00000355254.2 ENST00000317501.3 |
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3 |
| chr16_+_11439286 | 1.28 |
ENST00000312499.5
ENST00000576027.1 |
RMI2
|
RecQ mediated genome instability 2 |
| chr1_-_150693318 | 1.28 |
ENST00000442853.1
ENST00000368995.4 ENST00000368993.2 ENST00000361824.2 ENST00000322343.7 |
HORMAD1
|
HORMA domain containing 1 |
| chr1_-_228353112 | 1.28 |
ENST00000366713.1
|
IBA57-AS1
|
IBA57 antisense RNA 1 (head to head) |
| chr19_-_6110474 | 1.28 |
ENST00000587181.1
ENST00000587321.1 ENST00000586806.1 ENST00000589742.1 ENST00000592546.1 ENST00000303657.5 |
RFX2
|
regulatory factor X, 2 (influences HLA class II expression) |
| chr18_+_29078131 | 1.27 |
ENST00000585206.1
|
DSG2
|
desmoglein 2 |
| chr8_-_139926236 | 1.26 |
ENST00000303045.6
ENST00000435777.1 |
COL22A1
|
collagen, type XXII, alpha 1 |
| chr19_-_7990991 | 1.26 |
ENST00000318978.4
|
CTXN1
|
cortexin 1 |
| chr21_+_27011899 | 1.25 |
ENST00000425221.2
|
JAM2
|
junctional adhesion molecule 2 |
| chr2_+_176994408 | 1.25 |
ENST00000429017.1
ENST00000313173.4 ENST00000544999.1 |
HOXD8
|
homeobox D8 |
| chr12_-_65515334 | 1.24 |
ENST00000286574.4
|
WIF1
|
WNT inhibitory factor 1 |
| chr17_-_4710288 | 1.23 |
ENST00000571067.1
|
RP11-81A22.5
|
RP11-81A22.5 |
| chr14_-_27066636 | 1.23 |
ENST00000267422.7
ENST00000344429.5 ENST00000574031.1 ENST00000465357.2 ENST00000547619.1 |
NOVA1
|
neuro-oncological ventral antigen 1 |
| chr3_+_63638339 | 1.23 |
ENST00000343837.3
ENST00000469440.1 |
SNTN
|
sentan, cilia apical structure protein |
| chr15_+_41136216 | 1.23 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr15_-_58357932 | 1.22 |
ENST00000347587.3
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2 |
| chr16_+_31483451 | 1.22 |
ENST00000565360.1
ENST00000361773.3 |
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1 |
| chr10_-_100995603 | 1.21 |
ENST00000370552.3
ENST00000370549.1 |
HPSE2
|
heparanase 2 |
| chr2_-_224903995 | 1.21 |
ENST00000409304.1
ENST00000454956.1 ENST00000258405.4 |
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
| chr15_+_96875657 | 1.21 |
ENST00000559679.1
ENST00000394171.2 |
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr1_-_182922505 | 1.21 |
ENST00000367547.3
|
SHCBP1L
|
SHC SH2-domain binding protein 1-like |
| chr2_-_20425158 | 1.21 |
ENST00000381150.1
|
SDC1
|
syndecan 1 |
| chr15_+_96873921 | 1.21 |
ENST00000394166.3
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr8_-_132052458 | 1.21 |
ENST00000377928.3
|
ADCY8
|
adenylate cyclase 8 (brain) |
| chr6_-_31846744 | 1.21 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
| chr10_-_128077024 | 1.20 |
ENST00000368679.4
ENST00000368676.4 ENST00000448723.1 |
ADAM12
|
ADAM metallopeptidase domain 12 |
| chr5_-_168727713 | 1.20 |
ENST00000404867.3
|
SLIT3
|
slit homolog 3 (Drosophila) |
| chr9_-_127269488 | 1.20 |
ENST00000455734.1
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1 |
| chr10_-_100995540 | 1.19 |
ENST00000370546.1
ENST00000404542.1 |
HPSE2
|
heparanase 2 |
| chr2_+_26915584 | 1.19 |
ENST00000302909.3
|
KCNK3
|
potassium channel, subfamily K, member 3 |
| chr11_-_64490634 | 1.19 |
ENST00000377559.3
ENST00000265459.6 |
NRXN2
|
neurexin 2 |
| chr15_-_58357866 | 1.19 |
ENST00000537372.1
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2 |
| chr6_+_19837592 | 1.19 |
ENST00000378700.3
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
| chr2_+_176995011 | 1.18 |
ENST00000548663.1
ENST00000450510.2 |
HOXD8
|
homeobox D8 |
| chr14_-_53417732 | 1.18 |
ENST00000399304.3
ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2
|
fermitin family member 2 |
| chr17_-_48207115 | 1.18 |
ENST00000511964.1
|
SAMD14
|
sterile alpha motif domain containing 14 |
| chr2_-_216300784 | 1.18 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
| chr9_-_89562104 | 1.17 |
ENST00000298743.7
|
GAS1
|
growth arrest-specific 1 |
| chr19_-_46476791 | 1.17 |
ENST00000263257.5
|
NOVA2
|
neuro-oncological ventral antigen 2 |
| chr2_-_130956006 | 1.17 |
ENST00000312988.7
|
TUBA3E
|
tubulin, alpha 3e |
| chr12_-_48152428 | 1.17 |
ENST00000449771.2
ENST00000395358.3 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
| chr11_-_110583912 | 1.17 |
ENST00000533353.1
ENST00000527598.1 |
ARHGAP20
|
Rho GTPase activating protein 20 |
| chr8_-_60031762 | 1.17 |
ENST00000361421.1
|
TOX
|
thymocyte selection-associated high mobility group box |
| chr14_-_38064198 | 1.16 |
ENST00000250448.2
|
FOXA1
|
forkhead box A1 |
| chr9_-_96717654 | 1.16 |
ENST00000253968.6
|
BARX1
|
BARX homeobox 1 |
| chr16_-_2205352 | 1.16 |
ENST00000563192.1
|
RP11-304L19.5
|
RP11-304L19.5 |
| chr11_+_66188475 | 1.16 |
ENST00000311034.2
|
NPAS4
|
neuronal PAS domain protein 4 |
| chr1_-_45308616 | 1.16 |
ENST00000447098.2
ENST00000372192.3 |
PTCH2
|
patched 2 |
| chr16_-_66835480 | 1.16 |
ENST00000559050.1
ENST00000558713.2 ENST00000433154.1 ENST00000432602.1 ENST00000433574.1 ENST00000415744.1 |
CCDC79
|
coiled-coil domain containing 79 |
| chr11_-_119293872 | 1.16 |
ENST00000524970.1
|
THY1
|
Thy-1 cell surface antigen |
| chr22_+_42394780 | 1.15 |
ENST00000328823.9
|
WBP2NL
|
WBP2 N-terminal like |
| chr19_-_11308190 | 1.15 |
ENST00000586659.1
ENST00000592903.1 ENST00000589359.1 ENST00000588724.1 ENST00000432929.2 |
KANK2
|
KN motif and ankyrin repeat domains 2 |
| chr16_+_84178874 | 1.15 |
ENST00000378553.5
|
DNAAF1
|
dynein, axonemal, assembly factor 1 |
| chr6_+_84743436 | 1.15 |
ENST00000257776.4
|
MRAP2
|
melanocortin 2 receptor accessory protein 2 |
| chr10_+_112257596 | 1.15 |
ENST00000369583.3
|
DUSP5
|
dual specificity phosphatase 5 |
| chr7_-_130080977 | 1.15 |
ENST00000223208.5
|
CEP41
|
centrosomal protein 41kDa |
| chr16_+_29823552 | 1.15 |
ENST00000300797.6
|
PRRT2
|
proline-rich transmembrane protein 2 |
| chr10_-_105845674 | 1.15 |
ENST00000353479.5
ENST00000369733.3 |
COL17A1
|
collagen, type XVII, alpha 1 |
| chr5_+_172068232 | 1.14 |
ENST00000520919.1
ENST00000522853.1 ENST00000369800.5 |
NEURL1B
|
neuralized E3 ubiquitin protein ligase 1B |
| chr5_-_168727786 | 1.14 |
ENST00000332966.8
|
SLIT3
|
slit homolog 3 (Drosophila) |
| chr5_+_55033872 | 1.14 |
ENST00000515709.1
ENST00000506848.1 ENST00000514679.1 |
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 |
| chr14_+_24867992 | 1.14 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
| chr20_+_43374421 | 1.14 |
ENST00000372861.3
|
KCNK15
|
potassium channel, subfamily K, member 15 |
| chr11_+_34642656 | 1.14 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
| chr9_-_21994344 | 1.14 |
ENST00000530628.2
ENST00000361570.3 |
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
Network of associatons between targets according to the STRING database.
First level regulatory network of E2F6
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 9.6 | GO:0030421 | defecation(GO:0030421) |
| 1.5 | 4.5 | GO:1901254 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 1.0 | 6.1 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 1.0 | 3.0 | GO:0035566 | regulation of metanephros size(GO:0035566) |
| 1.0 | 3.0 | GO:0048627 | myoblast development(GO:0048627) |
| 1.0 | 5.0 | GO:0048749 | compound eye development(GO:0048749) |
| 0.9 | 4.5 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.9 | 2.6 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.9 | 6.0 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 0.8 | 1.6 | GO:0072040 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) negative regulation of somatic stem cell population maintenance(GO:1904673) |
| 0.8 | 2.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.8 | 2.3 | GO:0060629 | regulation of homologous chromosome segregation(GO:0060629) |
| 0.7 | 2.8 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.7 | 2.1 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.7 | 2.1 | GO:0002514 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 0.7 | 2.1 | GO:1902203 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 0.6 | 1.9 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.6 | 1.9 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 0.6 | 4.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.6 | 2.4 | GO:0009956 | radial pattern formation(GO:0009956) |
| 0.6 | 2.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.6 | 2.3 | GO:0072302 | posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.6 | 0.6 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
| 0.6 | 2.8 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.6 | 2.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.5 | 2.2 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.5 | 1.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.5 | 1.6 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.5 | 1.6 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 0.5 | 4.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.5 | 1.5 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.5 | 1.5 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.5 | 2.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.5 | 1.5 | GO:0072011 | mesangial cell-matrix adhesion(GO:0035759) glomerular endothelium development(GO:0072011) |
| 0.5 | 1.0 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.5 | 2.4 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 0.5 | 2.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.5 | 2.3 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.5 | 2.8 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.5 | 1.8 | GO:0048687 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.5 | 1.8 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.4 | 1.3 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 0.4 | 0.4 | GO:0060932 | His-Purkinje system cell differentiation(GO:0060932) |
| 0.4 | 3.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.4 | 0.9 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.4 | 0.4 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.4 | 2.6 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.4 | 1.3 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.4 | 0.8 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.4 | 1.2 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.4 | 1.2 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.4 | 1.2 | GO:0048925 | lateral line system development(GO:0048925) |
| 0.4 | 1.6 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 0.4 | 2.4 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
| 0.4 | 1.2 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.4 | 1.2 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.4 | 1.2 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.4 | 0.7 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
| 0.4 | 1.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.3 | 2.1 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
| 0.3 | 1.4 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.3 | 1.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.3 | 1.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.3 | 1.7 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.3 | 3.4 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
| 0.3 | 1.0 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.3 | 0.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.3 | 1.0 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.3 | 1.0 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.3 | 1.3 | GO:1900168 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 0.3 | 1.0 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.3 | 2.6 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.3 | 2.6 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.3 | 4.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.3 | 0.9 | GO:0003294 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 0.3 | 0.3 | GO:0100012 | regulation of heart induction(GO:0090381) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
| 0.3 | 1.2 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.3 | 0.6 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.3 | 1.5 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.3 | 1.5 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
| 0.3 | 0.6 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.3 | 1.8 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.3 | 2.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.3 | 4.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.3 | 2.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.3 | 2.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.3 | 1.6 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.3 | 1.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.3 | 1.6 | GO:1901911 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.3 | 4.0 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.3 | 0.8 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.3 | 0.8 | GO:0071789 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.3 | 0.3 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 0.3 | 1.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.3 | 1.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.3 | 0.5 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 0.3 | 0.5 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
| 0.3 | 3.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 | 2.0 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.2 | 1.0 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 | 0.2 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
| 0.2 | 1.7 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.2 | 0.7 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.2 | 1.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.2 | 1.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.2 | 0.2 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.2 | 0.7 | GO:2000721 | pilomotor reflex(GO:0097195) positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.2 | 0.7 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.2 | 1.4 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.2 | 0.7 | GO:0061743 | motor learning(GO:0061743) maintenance of synapse structure(GO:0099558) |
| 0.2 | 0.9 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.2 | 0.9 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.2 | 1.6 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.2 | 1.1 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.2 | 1.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 | 0.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 | 1.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.2 | 1.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 | 0.2 | GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) |
| 0.2 | 3.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.2 | 5.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 | 0.7 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 | 1.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.2 | 1.1 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.2 | 0.6 | GO:0021893 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.2 | 0.6 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.2 | 3.8 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
| 0.2 | 1.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.2 | 0.4 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
| 0.2 | 0.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.2 | 0.8 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.2 | 0.2 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.2 | 1.8 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.2 | 2.5 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.2 | 0.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.2 | 0.4 | GO:0010159 | specification of organ position(GO:0010159) |
| 0.2 | 0.4 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.2 | 1.0 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 0.2 | 3.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.2 | 3.7 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.2 | 1.2 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.2 | 2.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 | 1.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.2 | 0.6 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 | 4.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.2 | 2.5 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.2 | 0.6 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 | 0.7 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.2 | 0.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.2 | 0.6 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.2 | 1.8 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.2 | 5.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.2 | 0.7 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.2 | 1.7 | GO:0003383 | apical constriction(GO:0003383) |
| 0.2 | 1.6 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 | 0.5 | GO:2000775 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 0.2 | 0.5 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.2 | 1.8 | GO:1990834 | response to odorant(GO:1990834) |
| 0.2 | 1.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.2 | 0.7 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.2 | 0.4 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 0.2 | 0.4 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.2 | 1.9 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.2 | 0.7 | GO:0060685 | prostatic bud formation(GO:0060513) regulation of prostatic bud formation(GO:0060685) |
| 0.2 | 2.3 | GO:0007350 | blastoderm segmentation(GO:0007350) |
| 0.2 | 2.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 | 0.5 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.2 | 3.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.2 | 1.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 | 2.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.2 | 0.7 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 0.2 | 2.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.2 | 0.2 | GO:0050975 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.2 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.2 | 1.0 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.2 | 1.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 | 0.3 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 0.2 | 1.9 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.2 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 | 0.6 | GO:2000173 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.2 | 0.8 | GO:1903284 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.2 | 0.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.2 | 2.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.2 | 2.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.2 | 0.9 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
| 0.2 | 0.5 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.2 | 0.5 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.2 | 0.5 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.2 | 1.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.2 | 0.6 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.1 | 0.4 | GO:0071503 | response to heparin(GO:0071503) |
| 0.1 | 0.4 | GO:0021571 | rhombomere 5 development(GO:0021571) |
| 0.1 | 0.1 | GO:0048377 | lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 0.1 | 1.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.1 | 1.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.1 | 0.7 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
| 0.1 | 5.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 1.3 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
| 0.1 | 0.6 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.1 | 3.0 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 1.3 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.1 | 0.8 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 3.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.1 | 2.2 | GO:0060068 | vagina development(GO:0060068) |
| 0.1 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.1 | 0.8 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.1 | 0.5 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
| 0.1 | 0.7 | GO:0051592 | response to calcium ion(GO:0051592) |
| 0.1 | 0.3 | GO:0060596 | mammary placode formation(GO:0060596) |
| 0.1 | 0.8 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 | 0.4 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.1 | 1.7 | GO:0032342 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
| 0.1 | 0.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.1 | 0.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.1 | 1.3 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.1 | 2.2 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 0.4 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.1 | 3.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.1 | 0.6 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.1 | 1.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.1 | 0.9 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
| 0.1 | 1.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.1 | 0.8 | GO:0042335 | cuticle development(GO:0042335) |
| 0.1 | 1.9 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 | 0.4 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.1 | 2.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 | 0.5 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 | 2.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 0.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.1 | 0.6 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.1 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.1 | 0.8 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 0.2 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.1 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.5 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 | 0.9 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
| 0.1 | 1.7 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.1 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 0.1 | 0.1 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 0.1 | 1.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.1 | 1.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 2.8 | GO:0097205 | renal filtration(GO:0097205) |
| 0.1 | 0.4 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.1 | 0.6 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 | 1.0 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.1 | 2.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 | 0.2 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 | 1.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 | 1.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.1 | 0.2 | GO:0021502 | neural fold elevation formation(GO:0021502) |
| 0.1 | 1.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 | 0.5 | GO:0015862 | uridine transport(GO:0015862) |
| 0.1 | 0.7 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.1 | 0.3 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.1 | 0.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.1 | 0.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.1 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 | 1.3 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 | 0.8 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) Tie signaling pathway(GO:0048014) |
| 0.1 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.1 | 0.5 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 | 0.3 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
| 0.1 | 1.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.1 | 0.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 | 0.8 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 | 0.5 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.1 | 0.8 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 | 2.1 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.1 | 0.8 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.1 | 2.4 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.1 | 0.6 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 | 0.3 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.1 | 0.8 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.1 | 0.7 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.1 | 0.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.1 | 0.3 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.1 | 0.5 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.1 | 2.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.1 | 1.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 | 1.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.1 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 0.6 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 | 0.3 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.1 | 1.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.1 | 0.9 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 0.1 | 1.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.1 | 0.3 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.1 | 0.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.1 | 1.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.1 | 1.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 | 0.5 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 | 1.8 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.1 | 0.5 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.1 | 0.2 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.1 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 | 0.5 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 | 0.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 0.8 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.1 | 0.3 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 | 0.5 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.1 | 0.4 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.1 | 0.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 | 0.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 | 1.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.7 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.1 | 3.9 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 | 0.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.1 | 0.5 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 0.2 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.1 | 0.7 | GO:1901727 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 | 1.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 0.3 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 | 1.3 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.1 | 0.6 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.1 | 0.2 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.1 | 0.8 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.1 | 0.3 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 | 0.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 | 0.9 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 | 0.6 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.1 | 0.5 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 | 0.6 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.1 | 0.4 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
| 0.1 | 0.1 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 0.1 | 0.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 | 1.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.1 | 3.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
| 0.1 | 1.7 | GO:0060674 | placenta blood vessel development(GO:0060674) |
| 0.1 | 0.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 1.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 | 3.3 | GO:0007129 | synapsis(GO:0007129) |
| 0.1 | 1.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 0.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.1 | 0.8 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 1.2 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.1 | 2.8 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 | 0.4 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
| 0.1 | 1.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 0.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 | 0.5 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 2.9 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.1 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 0.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.1 | 1.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.1 | 0.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.1 | 1.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.1 | 0.4 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
| 0.1 | 0.3 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.1 | 0.3 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.1 | 1.1 | GO:0019614 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.1 | 0.6 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 0.1 | 0.1 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.1 | 2.5 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.1 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 | 0.3 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.1 | 0.4 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.1 | 0.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.1 | 0.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.1 | 1.4 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 | 1.8 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.1 | 0.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 0.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.1 | 2.2 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.1 | 0.2 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
| 0.1 | 8.8 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.1 | 0.2 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.1 | 1.3 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.1 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.1 | 0.9 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.1 | 0.2 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.1 | 2.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 | 0.1 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.1 | 0.2 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.1 | 1.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.1 | 0.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.1 | 0.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.2 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.1 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.1 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.1 | 0.4 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.1 | 0.2 | GO:0051447 | negative regulation of meiotic nuclear division(GO:0045835) negative regulation of meiotic cell cycle(GO:0051447) |
| 0.1 | 0.5 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.1 | 0.9 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.1 | 1.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
| 0.1 | 0.8 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.1 | 0.3 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
| 0.1 | 0.4 | GO:0048265 | response to pain(GO:0048265) |
| 0.1 | 1.4 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 | 0.2 | GO:2000282 | negative regulation of cardiac muscle adaptation(GO:0010616) regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) regulation of cellular amino acid biosynthetic process(GO:2000282) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.1 | 1.1 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 | 0.2 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.1 | 3.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.1 | 0.5 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
| 0.1 | 0.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.1 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 | 0.6 | GO:2001181 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.0 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.0 | 0.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.0 | 0.2 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.0 | 0.1 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.0 | 0.1 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.0 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.0 | 0.3 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
| 0.0 | 1.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 | 0.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.0 | 0.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 1.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 | 0.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.1 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.0 | 0.4 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.0 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.0 | 0.3 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
| 0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.0 | 0.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.0 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.0 | 2.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.0 | 0.2 | GO:0030070 | insulin processing(GO:0030070) |
| 0.0 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 | 0.4 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.0 | 0.0 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
| 0.0 | 0.7 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.0 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.0 | 3.1 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 0.0 | 0.8 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.0 | 1.1 | GO:0033622 | integrin activation(GO:0033622) |
| 0.0 | 1.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.0 | 1.1 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.0 | 0.3 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.0 | 0.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
| 0.0 | 0.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.0 | 0.1 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.0 | 0.4 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.0 | 0.3 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.0 | 1.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.0 | 0.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.0 | 0.3 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 1.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 | 0.4 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.0 | 0.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.0 | 0.2 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.0 | 0.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.0 | 0.5 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.0 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.0 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 | 0.2 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.0 | 0.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.0 | 0.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 | 0.4 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.0 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.0 | 0.2 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.0 | 0.2 | GO:0045682 | regulation of epidermis development(GO:0045682) |
| 0.0 | 4.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.2 | GO:0046959 | habituation(GO:0046959) |
| 0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 | 1.6 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
| 0.0 | 0.5 | GO:0015825 | L-serine transport(GO:0015825) |
| 0.0 | 0.3 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.0 | 2.9 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.0 | 0.9 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.0 | 0.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.0 | 0.8 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.0 | 0.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 0.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.0 | 0.6 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.0 | 0.7 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
| 0.0 | 0.2 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.0 | 0.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 | 0.5 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
| 0.0 | 0.4 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 | 0.1 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.0 | 0.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 | 0.6 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.0 | 1.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.0 | 2.3 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.0 | 0.3 | GO:1904377 | positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.0 | 0.7 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 | 0.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.0 | 0.1 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.0 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.0 | 2.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 | 0.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 1.0 | GO:0048536 | spleen development(GO:0048536) |
| 0.0 | 0.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
| 0.0 | 0.2 | GO:0046545 | development of primary female sexual characteristics(GO:0046545) |
| 0.0 | 0.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.0 | 0.2 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.0 | 0.2 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 | 0.4 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.0 | 1.1 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.0 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.0 | 0.3 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 | 0.2 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.0 | 0.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 | 2.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
| 0.0 | 0.3 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.0 | 0.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.0 | 0.3 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.0 | 0.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.0 | 0.1 | GO:1900737 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.0 | 0.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.0 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.0 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.0 | 0.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 | 0.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.0 | 0.2 | GO:0015744 | tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) succinate transmembrane transport(GO:0071422) |
| 0.0 | 0.7 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.0 | 0.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 | 0.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.0 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.0 | 1.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 | 0.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.0 | 0.2 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.0 | 1.2 | GO:0001706 | endoderm formation(GO:0001706) |
| 0.0 | 0.1 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.0 | 0.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.0 | 0.6 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 0.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.0 | 0.3 | GO:0009635 | response to herbicide(GO:0009635) |
| 0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.0 | 0.2 | GO:0038127 | ERBB signaling pathway(GO:0038127) |
| 0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.1 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.0 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
| 0.0 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.0 | 0.4 | GO:0033561 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.0 | 0.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.0 | 0.6 | GO:0000732 | strand displacement(GO:0000732) |
| 0.0 | 0.1 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.0 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.0 | 0.2 | GO:0001824 | blastocyst development(GO:0001824) |
| 0.0 | 0.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.0 | 0.8 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.0 | 0.4 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 | 0.2 | GO:0098773 | hair follicle development(GO:0001942) skin epidermis development(GO:0098773) |
| 0.0 | 0.5 | GO:0009650 | UV protection(GO:0009650) |
| 0.0 | 0.0 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.0 | 0.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 | 1.0 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.0 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
| 0.0 | 0.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.0 | 0.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.1 | GO:0033206 | meiotic chromosome movement towards spindle pole(GO:0016344) meiotic cytokinesis(GO:0033206) |
| 0.0 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 | 0.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.0 | 0.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 | 0.5 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
| 0.0 | 0.3 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.0 | 0.2 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.0 | 0.3 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.0 | 0.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.0 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.7 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.0 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.0 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 | 0.6 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.0 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.0 | 0.3 | GO:0033151 | V(D)J recombination(GO:0033151) |
| 0.0 | 0.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.0 | 1.3 | GO:0051298 | centrosome duplication(GO:0051298) |
| 0.0 | 0.8 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.0 | 0.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
| 0.0 | 0.3 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.0 | 1.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 1.0 | GO:0003341 | cilium movement(GO:0003341) |
| 0.0 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 | 0.3 | GO:0030728 | ovulation(GO:0030728) |
| 0.0 | 0.0 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.0 | 0.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.0 | 0.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 | 0.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.0 | 0.7 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.0 | 0.1 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
| 0.0 | 0.1 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.0 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.0 | 0.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 | 2.8 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 | 0.3 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 | 0.1 | GO:2001268 | urokinase plasminogen activator signaling pathway(GO:0038195) negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.0 | 0.9 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.0 | 0.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.0 | 0.3 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 | 0.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
| 0.0 | 0.8 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.0 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.0 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.0 | 0.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 | 0.2 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.0 | 0.2 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.0 | 0.3 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.0 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.0 | 0.5 | GO:0097502 | mannosylation(GO:0097502) |
| 0.0 | 0.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.1 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.0 | 0.0 | GO:0032970 | regulation of actin filament-based process(GO:0032970) |
| 0.0 | 0.9 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 4.5 | GO:1902737 | dendritic filopodium(GO:1902737) |
| 1.1 | 3.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 1.0 | 3.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 1.0 | 1.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.8 | 2.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.7 | 0.7 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.7 | 4.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.6 | 2.4 | GO:0030849 | autosome(GO:0030849) |
| 0.6 | 0.6 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 0.5 | 5.2 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.4 | 1.3 | GO:0001534 | radial spoke(GO:0001534) |
| 0.4 | 2.6 | GO:0071547 | piP-body(GO:0071547) |
| 0.4 | 1.9 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.4 | 1.8 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.3 | 1.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.3 | 1.3 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.3 | 5.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.3 | 2.7 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.3 | 8.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.3 | 1.2 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.3 | 0.8 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.3 | 1.9 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.3 | 1.1 | GO:0031523 | Myb complex(GO:0031523) |
| 0.3 | 1.3 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.2 | 0.7 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 0.2 | 0.7 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.2 | 1.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.2 | 2.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.2 | 1.1 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.2 | 0.8 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.2 | 0.8 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.2 | 3.6 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.2 | 1.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.2 | 3.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.2 | 2.5 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.2 | 0.6 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 0.2 | 2.7 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.2 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.2 | 3.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.2 | 1.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.2 | 0.6 | GO:0000811 | GINS complex(GO:0000811) |
| 0.2 | 8.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 0.7 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.1 | 1.0 | GO:0098536 | deuterosome(GO:0098536) |
| 0.1 | 1.0 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.1 | 6.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.1 | 0.8 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.1 | 1.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.1 | 4.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 0.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.1 | 0.4 | GO:0035101 | FACT complex(GO:0035101) |
| 0.1 | 2.0 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 0.4 | GO:1990742 | microvesicle(GO:1990742) |
| 0.1 | 0.4 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.1 | 1.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.1 | 1.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 2.3 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 0.5 | GO:0097125 | condensed nuclear chromosome outer kinetochore(GO:0000942) cyclin B1-CDK1 complex(GO:0097125) |
| 0.1 | 2.0 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 2.3 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 2.3 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 0.3 | GO:0031261 | nuclear pre-replicative complex(GO:0005656) DNA replication preinitiation complex(GO:0031261) pre-replicative complex(GO:0036387) |
| 0.1 | 0.5 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.1 | 0.8 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.1 | 4.1 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 3.2 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 1.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 0.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.1 | 1.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.1 | 1.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.1 | 1.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 0.5 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 0.8 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 2.2 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 0.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.1 | 0.6 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.1 | 1.5 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.1 | 2.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.1 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.1 | 2.0 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.1 | 0.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.1 | 6.2 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 1.0 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.1 | 9.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 2.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 3.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 0.2 | GO:0097196 | Shu complex(GO:0097196) |
| 0.1 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 8.6 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 0.8 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 8.7 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 0.3 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.1 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.1 | 2.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 1.1 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.1 | 1.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 1.8 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 2.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 5.9 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.0 | 0.2 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.0 | 1.9 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 0.0 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.0 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.0 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.0 | 0.2 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.0 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
| 0.0 | 0.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.0 | 0.4 | GO:0070069 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) cytochrome complex(GO:0070069) |
| 0.0 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.0 | 0.1 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.0 | 0.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.0 | 1.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.0 | 1.6 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.0 | 0.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.0 | 0.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.0 | 1.6 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
| 0.0 | 0.8 | GO:0008091 | spectrin(GO:0008091) |
| 0.0 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.0 | 19.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 2.4 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.0 | 0.4 | GO:0005638 | lamin filament(GO:0005638) |
| 0.0 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.0 | 2.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.0 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.0 | 3.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.0 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.0 | 0.5 | GO:0030315 | T-tubule(GO:0030315) |
| 0.0 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.0 | 6.9 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.0 | 0.1 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.0 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.0 | 4.8 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.0 | 5.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.0 | 0.7 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.0 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.0 | 0.1 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.0 | 0.7 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.0 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.0 | 1.9 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 1.3 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.0 | 0.1 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.0 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.0 | 6.9 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 0.7 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 1.7 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.1 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.0 | 0.1 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.0 | 0.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.0 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 21.5 | GO:0009986 | cell surface(GO:0009986) |
| 0.0 | 0.3 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.0 | 1.3 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.0 | 5.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 27.2 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.0 | 0.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 0.9 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.0 | 1.0 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 1.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 0.3 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.0 | 0.5 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.0 | 1.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.0 | 0.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 0.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.0 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.0 | 0.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.0 | 0.5 | GO:0043679 | axon terminus(GO:0043679) |
| 0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 3.7 | GO:0098793 | presynapse(GO:0098793) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 6.0 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 1.2 | 7.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.7 | 2.0 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.7 | 2.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.6 | 2.4 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.6 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.6 | 5.6 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.6 | 11.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.5 | 1.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.5 | 2.0 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 0.5 | 2.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.5 | 2.0 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.5 | 3.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.4 | 0.4 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
| 0.4 | 1.2 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.4 | 1.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.4 | 1.2 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.4 | 1.5 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
| 0.4 | 3.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.3 | 1.4 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.3 | 4.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.3 | 0.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.3 | 2.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.3 | 4.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.3 | 2.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.3 | 1.0 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.3 | 0.9 | GO:0016730 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 0.3 | 0.9 | GO:0086076 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
| 0.3 | 4.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.3 | 1.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.3 | 2.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.3 | 3.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.3 | 0.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.3 | 1.6 | GO:0052847 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.3 | 1.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.3 | 0.8 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.3 | 1.6 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.3 | 1.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.3 | 0.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 2.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.3 | 1.0 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.2 | 1.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.2 | 0.7 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.2 | 1.0 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.2 | 0.9 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.2 | 1.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.2 | 2.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.2 | 6.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.2 | 0.9 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.2 | 2.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.2 | 0.6 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 0.2 | 1.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.2 | 0.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 0.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.2 | 0.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.2 | 1.7 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.2 | 0.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.2 | 1.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.2 | 1.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.2 | 2.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.2 | 0.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.2 | 0.7 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.2 | 0.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.2 | 1.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.2 | 5.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.2 | 1.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.2 | 1.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.2 | 0.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.2 | 2.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.2 | 2.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.2 | 3.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.2 | 0.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.2 | 0.8 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.2 | 1.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.2 | 0.5 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.2 | 0.5 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.1 | 0.7 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.1 | 0.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.1 | 2.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 1.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 2.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 1.2 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.1 | 0.6 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.1 | 0.4 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.1 | 0.4 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.1 | 4.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 1.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 0.4 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
| 0.1 | 0.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.1 | 1.5 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 0.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 1.3 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
| 0.1 | 0.7 | GO:0005113 | patched binding(GO:0005113) |
| 0.1 | 0.9 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.1 | 1.0 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.1 | 3.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.4 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.1 | 3.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 3.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.1 | 1.1 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.1 | 0.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.1 | 2.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 1.7 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.1 | 0.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.1 | 0.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.1 | 0.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.1 | 0.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.1 | 0.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.1 | 0.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.1 | 0.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 0.1 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 2.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 3.4 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 1.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 3.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.1 | 1.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.1 | 4.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 3.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 1.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 1.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.1 | 0.5 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.1 | 0.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.1 | 1.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.1 | 0.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.1 | 4.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.7 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.1 | 0.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.1 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 1.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.1 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.1 | 3.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.1 | 0.4 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.1 | 0.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.1 | 0.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 1.3 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 0.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.1 | 1.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.1 | 0.8 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 0.7 | GO:0005534 | galactose binding(GO:0005534) |
| 0.1 | 1.2 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.1 | 2.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 1.9 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.5 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.1 | 0.6 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.1 | 0.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.1 | 2.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 0.6 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.1 | 1.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 1.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.1 | 5.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 0.5 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.1 | 2.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 0.3 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.1 | 9.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 1.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.1 | 1.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 0.4 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.1 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.1 | 1.3 | GO:0008061 | chitin binding(GO:0008061) |
| 0.1 | 0.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 0.8 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 14.3 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.1 | 2.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 1.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 0.4 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.1 | 0.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.1 | 0.4 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.1 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.3 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.1 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.1 | 0.5 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.1 | 2.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 11.1 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 0.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.1 | 0.4 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.1 | 0.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.1 | 0.3 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.1 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 0.2 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.1 | 0.5 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.1 | 0.5 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.1 | 0.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 2.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
| 0.1 | 0.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 0.9 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.1 | 2.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
| 0.1 | 0.2 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.1 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.1 | 0.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 2.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.1 | 2.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.1 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.1 | 0.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 0.9 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.0 | 0.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.0 | 0.3 | GO:0030619 | U1 snRNA binding(GO:0030619) |
| 0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
| 0.0 | 0.2 | GO:0004583 | alpha-1,3-mannosyltransferase activity(GO:0000033) dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.0 | 0.1 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.0 | 0.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.0 | 0.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 0.1 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.0 | 1.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.0 | 0.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 0.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.0 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.0 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.0 | 0.1 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.0 | 0.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.0 | 0.9 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.0 | 1.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 0.6 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.0 | 0.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.0 | 0.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.0 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.0 | 6.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.0 | 1.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.0 | 0.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.0 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 3.6 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.3 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.0 | 5.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 1.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 0.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.0 | 0.1 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.0 | 0.1 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 0.0 | 1.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 1.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.0 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.0 | 1.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.0 | 1.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 11.2 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.0 | 0.1 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.0 | 0.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.0 | 0.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.0 | 0.4 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.0 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.0 | 0.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.0 | 0.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.0 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.0 | 0.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.0 | 1.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 1.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.0 | 0.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.0 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 1.2 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 1.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.0 | 0.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 1.4 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 6.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.2 | GO:0017153 | citrate transmembrane transporter activity(GO:0015137) succinate transmembrane transporter activity(GO:0015141) tricarboxylic acid transmembrane transporter activity(GO:0015142) sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.0 | 0.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 2.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.0 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 2.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 0.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.0 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.0 | 1.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.0 | 0.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.0 | 0.2 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.0 | 0.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.0 | 1.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.0 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.0 | 0.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.0 | 7.3 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.0 | 3.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.0 | 0.7 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.0 | 0.5 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.0 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.0 | 1.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 1.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.0 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 0.0 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.0 | 0.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.0 | 0.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.0 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.0 | 0.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.0 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.0 | 1.4 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
| 0.0 | 0.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.0 | 0.6 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.0 | 0.0 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.0 | 0.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 0.0 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.0 | 1.2 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.0 | 0.3 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.0 | 0.7 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.1 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.0 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.0 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.0 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.0 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.0 | 0.6 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 0.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.0 | 1.2 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.3 | 18.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 18.3 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 5.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.2 | 6.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 5.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 1.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.1 | 3.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 0.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.1 | 3.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 1.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 3.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 2.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 3.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 2.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 5.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.1 | 9.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 23.2 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
| 0.1 | 1.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 1.1 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 4.4 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 26.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.1 | 2.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 0.3 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.1 | 1.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 2.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.0 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.0 | 1.2 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.0 | 3.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.0 | 0.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.0 | 3.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 2.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.0 | 0.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.0 | 1.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 1.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 2.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 1.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 1.4 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 1.6 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 9.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.0 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 10.8 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.0 | 1.8 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 1.0 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.0 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.0 | 4.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 0.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.0 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.0 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 0.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.4 | 2.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.4 | 13.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 4.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.2 | 18.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.2 | 0.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.1 | 3.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 2.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.1 | 4.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 0.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 2.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.1 | 5.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 1.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 3.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.1 | 3.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 6.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 5.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 2.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 3.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.1 | 1.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.1 | 2.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.1 | 1.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 1.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.1 | 1.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.1 | 3.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 2.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 3.2 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 2.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 1.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.1 | 2.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 2.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.1 | 3.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 3.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 1.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.1 | 1.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 1.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.1 | 1.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.0 | 0.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.0 | 1.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 1.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 0.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.0 | 1.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.0 | 2.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 3.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 0.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.0 | 1.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.0 | 0.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.0 | 0.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.0 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.0 | 1.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.0 | 1.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.0 | 1.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.0 | 0.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 4.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.0 | 2.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 2.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.0 | 0.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 0.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 0.2 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
| 0.0 | 0.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 0.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.0 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.0 | 0.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.0 | 0.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 5.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 1.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.8 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.0 | 0.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.0 | 2.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.0 | 0.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 1.2 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.0 | 2.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 0.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.0 | 4.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.0 | 1.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.2 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.0 | 0.2 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
| 0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.0 | 0.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |